Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Auto and Transport Industry News AXISCADES Technologies acquires Germany-based add-solution GmbH Indian engineering and technology solutions titan, AXISCADES Technologies Ltd. has announced its acquisition of add-solution GmbH, a prominent… byPallavi MadhirajuAugust 22, 2023